Insights on DHT compliance
EU MDR, FDA DHT guidance, EUDAMED, data integrity and the operational reality of digital health in clinical trials.
AllFDA28Wearables and sensors23Data integrity21EU MDR & IVDR20Digital endpoints17AI and machine learning15Risk management15Validation12ICH E6(R3)10Decentralised trials6Cybersecurity4Market & strategy4Inspection readiness3Vendor oversight3Change control2Economic operators2BYOD1Data protection1Interoperability1Software & SaMD1
3 articles tagged “Inspection readiness”
7 Jul 2026
Not in EUDAMED? If You Import the Device, the Obligations Are Already Yours
Who is the importer of record for the devices in your trial — and does that person know it? If a device on your study isn’t in EUDAMED, can you still legally…
Read article →
7 Apr 2026
The May 2026 EUDAMED Deadline: What It Means for Digital Health Technologies in Clinical Trials
The first EUDAMED modules became mandatory on 28 May 2026 — is the wearable sensor in your trial registered, and did it need to be? What happens to your EU clinical trial if the device manufacturer…
Read article →
4 Dec 2025
Quality-by-Design for DCTs: Turning FDA’s DHT Framework Into an Inspection-Ready Reality
Could your digital endpoints survive if an FDA inspector asked you to “show how this was generated”? Are your device, algorithm, and data teams aligned—or…
Read article →